Cargando…
Pharmacist Prescriptive Authority: Lessons from Idaho
Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. Thi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559090/ https://www.ncbi.nlm.nih.gov/pubmed/32650367 http://dx.doi.org/10.3390/pharmacy8030112 |
_version_ | 1783594781592518656 |
---|---|
author | Adams, Alex J. |
author_facet | Adams, Alex J. |
author_sort | Adams, Alex J. |
collection | PubMed |
description | Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho’s approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues. |
format | Online Article Text |
id | pubmed-7559090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75590902020-10-29 Pharmacist Prescriptive Authority: Lessons from Idaho Adams, Alex J. Pharmacy (Basel) Letter Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho’s approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues. MDPI 2020-07-08 /pmc/articles/PMC7559090/ /pubmed/32650367 http://dx.doi.org/10.3390/pharmacy8030112 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Letter Adams, Alex J. Pharmacist Prescriptive Authority: Lessons from Idaho |
title | Pharmacist Prescriptive Authority: Lessons from Idaho |
title_full | Pharmacist Prescriptive Authority: Lessons from Idaho |
title_fullStr | Pharmacist Prescriptive Authority: Lessons from Idaho |
title_full_unstemmed | Pharmacist Prescriptive Authority: Lessons from Idaho |
title_short | Pharmacist Prescriptive Authority: Lessons from Idaho |
title_sort | pharmacist prescriptive authority: lessons from idaho |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559090/ https://www.ncbi.nlm.nih.gov/pubmed/32650367 http://dx.doi.org/10.3390/pharmacy8030112 |
work_keys_str_mv | AT adamsalexj pharmacistprescriptiveauthoritylessonsfromidaho |